SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-021514
Filing Date
2023-04-28
Accepted
2023-04-28 16:05:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A ny20007761x2_defa14a.htm DEFA14A 6602
2 ny20007761x2_nc01.jpg GRAPHIC 299098
3 ny20007761x2_nc02.jpg GRAPHIC 225479
  Complete submission text file 0001140361-23-021514.txt   705219
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-31326 | Film No.: 23865902
SIC: 2836 Biological Products, (No Diagnostic Substances)